Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established During Phase II Clinical Trials for the Development of Org 36286 (Corifollitropin Alfa).
Brief Summary: The objective of this trial was to evaluate whether Org 36286 treatment in any Phase IIa clinical development trial of Org 36286 for OI or COH in assisted reproductive treatment programs was safe for pregnant subjects and their offspring. Data from subjects who participated in Trials 38805 and 38807 and became pregnant were evaluated.


Options:
A: Arm Label: 150 µg Corifollitropin Alfa; Type: EXPERIMENTAL; Interventions: Drug: Corifollitropin alfa, Drug: Placebo RecFSH / follitropin beta, Biological: RecFSH / Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Arm Label: 200 IU recFSH; Type: ACTIVE_COMPARATOR; Interventions: Biological: RecFSH / Follitropin beta (Days 1 to 7), Drug: Placebo Corifollitropin alfa, Biological: RecFSH / Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Intervention Type: DRUG; Name: Corifollitropin alfa; Assigned to Arm(s): 150 µg Corifollitropin Alfa | Intervention Type: BIOLOGICAL; Name: RecFSH / Follitropin beta (Days 1 to 7); Assigned to Arm(s): 200 IU recFSH | Intervention Type: DRUG; Name: Placebo Corifollitropin alfa; Assigned to Arm(s): 200 IU recFSH | Intervention Type: DRUG; Name: Placebo RecFSH / follitropin beta; Assigned to Arm(s): 150 µg Corifollitropin Alfa | Intervention Type: BIOLOGICAL; Name: RecFSH / Follitropin beta (Days 8 to hCG); Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH | Intervention Type: DRUG; Name: Ganirelix; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH | Intervention Type: BIOLOGICAL; Name: hCG; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH | Intervention Type: BIOLOGICAL; Name: Progesterone; Assigned to Arm(s): 150 µg Corifollitropin Alfa, 200 IU recFSH
B: Arm Label: Mothers Corifollitropin Alfa 150 µg; Type: N/A; Interventions: Drug: Corifollitropin Alfa 150 μg, Drug: Placebo for RecFSH/Follitropin beta, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Arm Label: Mothers recFSH 200 IU; Type: N/A; Interventions: Biological: 200 IU RecFSH/Follitropin beta (Days 1 to 7), Drug: Placebo for Corifollitropin Alfa, Biological: 200 IU RecFSH/Follitropin beta (Days 8 to hCG), Drug: Ganirelix, Biological: hCG, Biological: Progesterone | Intervention Type: DRUG; Name: Corifollitropin Alfa 150 μg; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 1 to 7); Assigned to Arm(s): Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Placebo for Corifollitropin Alfa; Assigned to Arm(s): Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Placebo for RecFSH/Follitropin beta; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg | Intervention Type: BIOLOGICAL; Name: 200 IU RecFSH/Follitropin beta (Days 8 to hCG); Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: DRUG; Name: Ganirelix; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: BIOLOGICAL; Name: hCG; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU | Intervention Type: BIOLOGICAL; Name: Progesterone; Assigned to Arm(s): Mothers Corifollitropin Alfa 150 µg, Mothers recFSH 200 IU
C: Arm Label: Corifollitropin alfa 150 µg; Type: EXPERIMENTAL; Interventions: Drug: Corifollitropin alfa, Biological: FSH, Biological: GnRH antagonist, Biological: (rec)hCG, Drug: Progesterone | Intervention Type: DRUG; Name: Corifollitropin alfa; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: FSH; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: GnRH antagonist; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: BIOLOGICAL; Name: (rec)hCG; Assigned to Arm(s): Corifollitropin alfa 150 µg | Intervention Type: DRUG; Name: Progesterone; Assigned to Arm(s): Corifollitropin alfa 150 µg
D: Arm Label: Experimental Group 1; Type: N/A; Interventions: Drug: Org 36286 (corifollitropin alfa) | Arm Label: Experimental Group 2; Type: N/A; Interventions: Drug: Placebo | Arm Label: Experimental Group 3; Type: N/A; Interventions: Drug: Org 36286 (corifollitropin alfa) | Arm Label: Experimental Group 4; Type: N/A; Interventions: Drug: recFSH | Intervention Type: DRUG; Name: Org 36286 (corifollitropin alfa); Assigned to Arm(s): Experimental Group 1, Experimental Group 3 | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Experimental Group 2 | Intervention Type: DRUG; Name: recFSH; Assigned to Arm(s): Experimental Group 4

Answer: D